Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07259603

Association Between Vitamin D Deficiency and Inflammatory Bowel Disease

Crohn's disease (CD) and ulcerative colitis (UC) are two major types of inflammatory bowel disease (IBD) that are identified by different clinical, endoscopic, pathological, and radiologic diagnostic methods.

In the past few years, the incidence of inflammatory bowel disease has been increasing worldwide, with the incidence of UC being higher than that of CD.

Vitamin D is a fat-soluble vitamin that is produced in the skin by a UV-dependent reactionand then hydroxylated by the kidneys and liver, and is converted to its active form, 1,25-dihydroxyvitamin D.

Vitamin D deficiency is common throughout the world and its deficiency rates ranging from 30 to 50% have been reported.

Several studies have shown the role of vitamin D as a regulator of the immune system and its inhibitory function incellular immunity and production of pro-inflammatory cytokines that play a major role in autoimmune diseases.

In some human studies, the link between vitamin D levels and the disease severity of IBD has been shown, but it is not clear whether lack of vitamin D is the cause or consequence.

In this study, we aimed to investigate the relationship between inflammatory bowel disease and itsflare-up with serum levels of vitamin D

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged ≥18 years
  • Diagnosed with crohn's and ulcerative colitis
  • Regular follow-up in IBD clinic
  • Recent vitamin D and disease activity assessment (within 1 month)

Exclusion criteria

  • Current vitamin D supplementation(>1000IU/day)
  • History of malabsorption syndromes (e.g.,celiac disease)
  • Chronic kidney or liver disease
  • Pregnancy

Treatment and study plan

Serum 25(OH)D (Vitamin D3), C- reactive protein, Erthrocyte sedimentation rate

Diagnostic Test

Serum 25(OH)D (Vitamin D3), C- reactive protein, Erthrocyte sedimentation rate are evaluated to assess vitamin D deficiency and IBD activity

Primary outcomes

  1. Prevalence of vitamin D deficiency in patients with active inflammatory bowel disease

    Time frame: Recent vitamin D and disease activity assessment (within 1 month)

    This will be done by measuring the vitamin D level in the serum of patients with active inflammatory bowel diseases (in nanograms/ milliliter)

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed A. Maghraby, Lecturer of internal medicine

CONTACT

[email protected]

01122871357

Noor el-Deen A. Mohamed, Professor of internal medicine

CONTACT

[email protected]

01005035180

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Association Between Vitamin D Deficiency and Disease Activity in Patients With Inflammatory Bowel Disease

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Dec 2, 2025
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.